Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€1.67
Target price
01.04.25
-
Performance (%)
-13.50%
Price
02.05.24
€1.44
Summary
This prediction is currently active. The price of Corvus Pharmaceuticals Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.50%. This prediction currently runs until 01.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corvus Pharmaceuticals Inc | 5.045% | 5.045% |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
-4.11%
02.05.24
02.05.24